Abstract
An impaired oesophageal clearance is characteristically found in children with CBPD (1). In a double-blind, placebo controlled cross-over setting, we studied the effect of the digestive prokinetic drug cisapride (CIS) in 14 infants and children with CPBD (median age : 29 months) by continuous monitoring of the lower oesophageal pH. CIS was dosed at 0.3 mg/kg 4 hours before the start of the measurements, followed by 3 times 0.15 mg/kg every 4 hours. Placebo (PLAG) administration was matched. Results show that, both during the total recording period and during sleep, the % time during which pH was < 4 (t4) and the No. of gastro-oesophageal (GOR) episodes of at least 5 minutes (N5) were significantly (p ≤ 0.05) reduced by CIS as compared to PLAC.
Conclusion : CIS objectively reduces GOR in children, primarily by reducing the number of long duration GOR episodes, which characterize these patients. Clinical trials of CIS in children with CBPD seem justified.
(1) C. Hoyoux, P. Forget, F. Geubelle. Pediatric Pulmonology 1:149-153, 1985.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Forget, P., Saye, P. EFFECT OF CISAPRIDE ON GASTRO-OESOPHAGEAL REFLUX IN CHILDREN WITH CHRONIC BRONCHOPULMONARY DISEASE (CBPD) A pH-METRIC STUDY. Pediatr Res 20, 699 (1986). https://doi.org/10.1203/00006450-198607000-00086
Issue Date:
DOI: https://doi.org/10.1203/00006450-198607000-00086